A metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
Solubility:
As Reported
Atmoshpere:
Inert Gas
Melting Point:
As Reported
Method for Determining Identity:
Proton NMR (CD3OD) Spectroscopic and Mass Spectrometric Analysis
TLC Conditions:
As Reported
Sodium Content:
As Reported
Storage and Stability:
May be stored at RT for short-term only. Long-term storage is recommended at -20 degrees C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Store under inert atmosphere.
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards:
Quick Search
Products 
